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ABSTRACT
Objective: Self-medication is a worldwide practice in which individuals, families, and/or communities choose pharmaceuticals to address health 
conditions without consulting a doctor. It impacts the health of people both negatively as well as positively. This study aims to determine the prevalence 
of self-medication for COVID-19 like symptoms during the pandemic.
Methods: This is an online questionnaire-based survey on the perceptions and use of certain drugs for COVID-like symptoms during the COVID-19 
pandemic. 168 people responded to the questionnaire.
Results: Out of 168 respondents, 53.0% were males. 71.4% were below 30 years of age and, 25.6% were 31–60 years. The majority (72.6%) were 
unmarried. 50.0% had studied up to university level. 49.4% were unemployed. 39.9% were healthcare workers. 59.9% had suffered from respiratory 
symptoms during the COVID-19 pandemic. All those who developed symptoms had self-medicated. The most commonly used drugs were Paracetamol 
(85.0%), Azithromycin (58.0%), Expectorants (30.0%), Ivermectin (18.0%), Doxycycline (16.0%), Corticosteroids (7.0%), and Hydroxychloroquine 
(4.0%). The major sources of information about the disease and drugs were pharmacists (46.6%) and the internet (28.0%).
Conclusion: There were significant percentages of self-medication during the COVID-19 pandemic, including the drugs without sufficient scientific evidence.
Keywords: Covid-19, Pandemic, Self-medication, Drugs, Healthcare.
INTRODUCTION
Self-medication is the use of medicinal products by individuals to treat 
self-identified diseases or symptoms. It also involves the intermittent 
or continuous use of medication prescribed by a physician to address 
chronic or recurrent illness or symptoms, obtaining medications 
without a prescription or resubmitting outdated prescriptions to obtain 
medications, sharing medications with family or friends, or consuming 
leftover medication, or failing to follow a professional prescription, 
either by prolonging or interrupting it too soon, or decreasing or raising 
the originally intended dose [1].
Self-medication encourages patients to be more self-reliant in making 
decisions about minor disease management. However, on the other 
hand, it carries dangers such as misdiagnosis, excessive drug dosage, 
long-term use, drug interactions, and polypharmacy [2].
The healthcare system worldwide has been challenged by the COVID-19 
outbreak. Fear and anxiety have crept in as a result of the lack of a 
specific cure for this viral infection. The general public’s perplexity 
at the issue has resulted in an increase in self-medication, including 
home remedies, with no established safety or efficacy. Furthermore, 
recommendations from friends, relatives, neighbors, pharmacists, and 
prescriptions from other Covid-positive patients have lead to an increase 
in self-medication [3]. Many people ceased visiting healthcare facilities 
for medical interventions due to concerns about getting COVID-19 in 
a hospital setting and the ease with which they can obtain drugs [4]. 
Self-Medication was exacerbated by the fake news epidemic that 
accompanied the COVID-19 pandemic as well as the widespread media 
coverage of any study related to a potential preventive or treatment 
approach [5]. The present study aims to assess the prevalence of self-
medication for COVID-19 like symptoms during the pandemic.
METHODS
We performed an online questionnaire-based survey, in May 2021, 
at SKIMS Hospital, Srinagar, on the use of some drugs that were 
presumably effective in the prevention or treatment of covid-19. The 
questionnaire was developed with Google forms, pretested, and sent by 
email or Whatsapp to 203 people selected by convenience sampling. 35 
respondents had answered incompletely. Hence the data of only 168 
participants were considered for the study and the rest were excluded. 
The questionnaire had two sections. Sections one asked questions 
about various demographic variables such as gender, age, marital 
status, educational qualification, and employment. Section two asked 
questions about the respiratory symptoms and drugs used during 
the COVID-19 pandemic. It also asked questions about the patient’s 
perceptions about drug use. The responses received were anonymized.
Inclusion criteria
Age above 18 years, can communicate by speaking or writing, willing to 
participate in the study.
Exclusion criteria
Age below 18 years, cannot communicate by speaking or writing, 
willing to participate in the study.
Data entry and analysis
Data were entered into a computer, and analysis was done by a 
combination of manual calculators and online Vassar Stats. Descriptive 
statistics were used.
RESULTS
Table 1 shows the demographic characteristics of the study population. 
53.0% (n=89) participants were males and 46.4% (n=78) females. 
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One participant chose not to reveal the gender. The age of 71.4% 
(n=120) was below 30 years, 25.6% (n=43) 31–60 years and 3.0% 
(n=5) above 60 years. 27.4% (n=46) were married and 72.6% (n=122) 
were unmarried. 0.6% (n=1) were illiterate, 5.4% (n=9) had received 
education up to school level, 44.0% (n=74) up to college level and 
50.0% (N=84) up to university level. 49.4% (n=83) were unemployed, 
11.3% (n=19) self-employed, 25.6% (n=43) private sector employees 
and 13.7% (n=23) were government employees. 39.9% (n=67) were 
healthcare workers.
Table 2 shows 59.5% (n=100) participants suffered from covid-19 like 
symptoms. 72.0% (n=72) of those who had symptoms got tested for 
covid-19, out of which 44.5% (n=32) tested positive.
Table 3 shows that 70.0% (n=70) participants had fever, 95.0% 
(n=95) headache, 59% (n=59) body aches, 34.0% (n=34) sneezing, 
50.0% (n=50) sore throat, 32.0% (n=32) nasal congestion, 45.0% 
(n=45) cough, 14.0% (n=14) breathlessness, and 39.0% (n=39) 
other symptoms. All the participants (n=100) who got Covid-19 like 
symptoms took a drug or combination of drugs. 85.0% (n=85) took 
paracetamol, 13.0% (n=13) ibuprofen, 18.0% (n=18) ivermectin, 
58.0% (n=58) azithromycin, 1.0% (n=1) budesonide, 30.0% (n=30) 
cough syrup, 16.0% (n=16) doxycycline, 3.0% (n=3) penicillins, 
4.0% (n=4) hydroxychloroquine, 2.0% (n=2) remdisivir, 7.0% (n=7) 
dexamethasone, 3.0% (n=3) famotidine, and 19.0% (n=19) other drugs.
Table 4 shows that 51.0% (n=51) of the participants with symptoms, 
thought that these drugs will prevent or treat covid-19. 49.0% (n=49) 
revealed that they usually take these drugs during flu-like symptoms.
Table 5 shows the source(s) of information about covid-19 in the 
study group. 28.0 (n=47) got information about the disease and drugs 
from Internet, 0.6% (n=1) radio, 5.4% (n=9) television, 2.4% (n=4) 
news papers, 13.1% (n=22) books/magazines/journals, 8.3% (n=14) 
friends, 18.5% (n=31) family, 44.6% (n=75) pharmacists/healthcare 
professionals, and 17.7% (n=29) from various other sources.
DISCUSSION
Self-medication is a global phenomenon. It has traditionally been 
defined as “the taking of medicine by oneself.” On one’s own initiative, 
without consulting a doctor. Families, friends, neighbors, the 
pharmacist, suggestions from an advertisement in newspapers, TV or 
magazines are common sources of information [6]. Self-medication, 
when done correctly, can be beneficial to an individual’s health and 
is recognized by the WHO as a kind of self-care [7]. Incorrect self-
diagnosis, delays in seeking medical advice when needed, severe 
adverse reactions, dangerous drug interactions, incorrect method 
of administration, incorrect dosage, incorrect choice of therapy, 
masking of severe disease, and the risk of dependence and abuse are 
Table 4: Perceptions about drugs used
Perception No. %
Will prevent/treat covid-19 51 51.0
Usually take these drugs for such symptoms 49 49.0




Body aches 59 59.0
Sneezing 34 34.0
Sore throat 50 50.0























N.B: Due to multiple options respondents could select, sum of %age is not 100





News papers 4 2.4





N.B: Due to multiple options respondents could select, sum of %age is not 100
Table 2: Suffered from symptoms/tests done
Variable No. %
Suffered from covid-19 like symptoms during pandemic
Yes 100 59.5
No 68 40.5











Preferred not to disclose 1 0.6
Age
Below 30 years 120 71.4
31–60 years 43 25.6





No education 1 0.6
School level 9 5.4
College level 74 44.0
University level 84 50.0
Profession
Unemployed 83 49.4
Self employed 19 11.3
Private job 43 25.6
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all potential risks of self-medication [8]. The COVID-19 epidemic is 
wreaking havoc around the globe. As of July 22, 2021, 191,773,590 
confirmed cases of COVID-19, including 4,127,963 deaths have been 
reported to World Health Organization [9]. The pandemic has caused 
challenges to healthcare systems around the world since it requires 
novel treatment and prevention strategies to deal with the impact of the 
pandemic. Medical professionals and patients are both battling with the 
“unknown.” The pandemic has led to a panic-driven, almost compulsive, 
reliance on various social media platforms among the general people, 
resulting in disinformation regarding pharmaceuticals and increased 
self-medication, including home remedies, with no documented safety 
or efficacy. The present study aims to assess the prevalence of self-
medication for COVID-19 like symptoms.
We found that all the participants who had covid-19 like symptoms self-
medicated. 51.0% of participants used the drugs to prevent or treat the 
disease/symptoms and 49.0% admitted that they usually take these drugs 
for such symptoms. The major symptoms were fever (70.0%), headache 
(95.0%), body aches (59.0%), sore throat (50.0%) and cough (45.0%). 
The most commonly used drugs were Paracetamol (85.0%), Azithromycin 
(58.0%), Expectorants (30.0%), Ivermectin (18.0%), Doxycycline (16.0%), 
Corticosteroids (7.0%), Hydroxychloroquine (4.0%) and Famotidine 
(3.0%). The major sources of information about the disease and drugs 
were pharmacists (46.6%) and the internet (28.0%).
We also found self-medication more prevalent in males (71.9%), above 
60 years age (100%), those with Post-graduate qualification (80.9%), 
and government employees (73.9%), as compared to other comparative 
groups. There was no difference in self-medication prevalence between 
healthcare workers and others.
As per a Google trends study, since the global corona virus pandemic 
was declared in 2019, there has been a relative increase in the number 
of people searching for information about self-medication of various 
ailments, which might also indicate that there has been an increased 
interest in the number of people browsing about self-medication of 
various ailments during the pandemic [10].
In a study on self-medication practices during the Covid-19 pandemic, 
it was found that the majority of respondents self-medicated with 
Acetaminophen, Ibuprofen, Azithromycin, Penicillin, Antiretrovirals, 
and Hydroxychloroquine for flu-like symptoms [5]. One study found 
low self-medication during the pandemic [11].
In an editorial commentary, Molento has expressed the concerns 
about self-medication with ivermectin during the Covid-19 pandemic 
as it is advocated over broad audiences at official pharmaceutical 
homepages, YouTube channels, and TV interviews. There is strong 
evidence showing that people self-medicate using antibiotics such as 
azithromycin and Hydroxychloroquine [12]. Iftikhar et al. found that 
About 15% of the participants took conventional and homeopathic 
medicines prophylactically in order to lower the risk of being infected 
with the coronavirus. Paracetamol was the most commonly used drug, 
followed by Fexofenadine, Zinc, Montelukast, and Ivermectin. People 
also took antibiotics including Azithromycin, Doxycycline, Amoxicillin, 
Levofloxacin, Linezolid, and Cephalosporins [13].
Limitations
In our study, there are some limitations. The validity of our findings 
relies primarily on the accuracy of responses. We tried to minimize 
recall bias by using a well-structured pre-validated questionnaire. 
Another limitation of this study is the limited sample size. The 
convenience sampling method used in the study has the possibility of 
under-or over-representation of the population and the results of the 
survey can not be generalized to the population as a whole. The design 
of the study does not ensure that the study population is representative 
of the general population.
CONCLUSION
Self-medication is common in both the developed as well as developing 
countries. The growth of information and communication has resulted 
in easy access to medical knowledge. Easy access to drugs, the influence 
of advertisements and previous experience of treating similar illness 
has influenced the practice of self-medication. During the current 
pandemic, self-medication for covid-19 like symptoms is widespread 
for a variety of reasons. Continuous awareness and sensitization about 
the risks of self-medication are warranted.
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